Want to see THC full AI Analyst Report?
Tenet Healthcare (THC) Ratios
Tenet Healthcare Ratios
THC's free cash flow for Q3 2026 was $1.08B. For the 2026 fiscal year, THC's free cash flow was decreased by $-198.00M and operating cash flow was $1.28B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.76 | 1.78 | 1.51 | 1.34 | 1.38 |
| Quick Ratio | 1.68 | 1.70 | 1.42 | 1.25 | 1.31 |
| Cash Ratio | 0.65 | 0.70 | 0.26 | 0.19 | 0.46 |
| Solvency Ratio | 0.11 | 0.20 | 0.06 | 0.06 | 0.08 |
| Operating Cash Flow Ratio | 0.79 | 0.47 | 0.50 | 0.24 | 0.31 |
| Short-Term Operating Cash Flow Coverage | 44.81 | 6.92 | 19.78 | 7.47 | 11.61 |
| Net Current Asset Value | $ -12.86B | $ -12.71B | $ -15.64B | $ -16.57B | $ -16.25B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.44 | 0.50 | 0.53 | 0.56 | 0.57 |
| Debt-to-Equity Ratio | 3.12 | 3.43 | 9.33 | 13.20 | 15.22 |
| Debt-to-Capital Ratio | 0.76 | 0.77 | 0.90 | 0.93 | 0.94 |
| Long-Term Debt-to-Capital Ratio | 0.76 | 0.75 | 0.90 | 0.93 | 0.94 |
| Financial Leverage Ratio | 7.03 | 6.94 | 17.61 | 23.78 | 26.83 |
| Debt Service Coverage Ratio | 4.50 | 5.09 | 3.02 | 2.64 | 3.08 |
| Interest Coverage Ratio | 4.19 | 7.21 | 2.79 | 2.62 | 3.11 |
| Debt to Market Cap | 0.74 | 1.06 | 1.95 | 2.89 | 1.79 |
| Interest Debt Per Share | 155.21 | 156.37 | 156.47 | 149.34 | 155.09 |
| Net Debt to EBITDA | 2.29 | 1.64 | 4.07 | 4.62 | 3.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 82.26% | 39.72% | 37.98% | 36.76% | 37.30% |
| EBIT Margin | 16.99% | 29.39% | 12.25% | 11.66% | 14.43% |
| EBITDA Margin | 21.04% | 33.35% | 16.49% | 16.04% | 18.81% |
| Operating Profit Margin | 16.14% | 28.82% | 12.22% | 12.17% | 14.73% |
| Pretax Profit Margin | 13.14% | 25.40% | 7.87% | 7.01% | 9.69% |
| Net Profit Margin | 6.60% | 15.49% | 2.97% | 2.14% | 4.69% |
| Continuous Operations Profit Margin | 11.11% | 19.67% | 6.38% | 5.22% | 7.58% |
| Net Income Per EBT | 50.25% | 60.98% | 37.79% | 30.56% | 48.41% |
| EBT Per EBIT | 81.42% | 88.11% | 64.42% | 57.65% | 65.76% |
| Return on Assets (ROA) | 4.74% | 11.06% | 2.16% | 1.51% | 3.31% |
| Return on Equity (ROE) | 33.34% | 76.72% | 38.00% | 35.99% | 88.91% |
| Return on Capital Employed (ROCE) | 13.64% | 24.19% | 10.66% | 10.29% | 12.78% |
| Return on Invested Capital (ROIC) | 11.49% | 18.51% | 8.60% | 7.61% | 9.94% |
| Return on Tangible Assets | 8.21% | 18.99% | 3.67% | 2.63% | 5.43% |
| Earnings Yield | 7.85% | 26.16% | 7.95% | 7.88% | 10.47% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.31 | 6.77 | 6.04 | 5.54 | 5.89 |
| Payables Turnover | 2.78 | 9.63 | 9.05 | 8.06 | 9.40 |
| Inventory Turnover | 10.86 | 36.00 | 31.00 | 29.94 | 31.82 |
| Fixed Asset Turnover | 2.86 | 2.92 | 2.81 | 2.53 | 2.62 |
| Asset Turnover | 0.72 | 0.71 | 0.73 | 0.71 | 0.71 |
| Working Capital Turnover Ratio | 6.31 | 7.15 | 10.51 | 11.05 | 9.14 |
| Cash Conversion Cycle | -53.79 | 26.16 | 31.91 | 32.82 | 34.56 |
| Days of Sales Outstanding | 43.93 | 53.94 | 60.47 | 65.90 | 61.93 |
| Days of Inventory Outstanding | 33.60 | 10.14 | 11.77 | 12.19 | 11.47 |
| Days of Payables Outstanding | 131.32 | 37.92 | 40.33 | 45.27 | 38.84 |
| Operating Cycle | 77.54 | 64.08 | 72.24 | 78.09 | 73.40 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 39.27 | 21.12 | 23.36 | 10.13 | 14.68 |
| Free Cash Flow Per Share | 28.06 | 11.52 | 15.97 | 3.00 | 8.52 |
| Dividend Paid and CapEx Coverage Ratio | 3.50 | 2.20 | 3.16 | 1.42 | 2.38 |
| Capital Expenditure Coverage Ratio | 3.50 | 2.20 | 3.16 | 1.42 | 2.38 |
| Operating Cash Flow Coverage Ratio | 0.27 | 0.14 | 0.16 | 0.07 | 0.10 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.10 | 0.12 | 0.06 | 0.08 |
| Free Cash Flow Yield | 14.12% | 9.12% | 21.13% | 6.15% | 10.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.73 | 3.82 | 12.57 | 12.69 | 9.55 |
| Price-to-Sales (P/S) Ratio | 0.84 | 0.59 | 0.37 | 0.27 | 0.45 |
| Price-to-Book (P/B) Ratio | 4.25 | 2.93 | 4.78 | 4.57 | 8.49 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.08 | 10.96 | 4.73 | 16.25 | 9.59 |
| Price-to-Operating Cash Flow Ratio | 5.06 | 5.98 | 3.24 | 4.82 | 5.57 |
| Price-to-Earnings Growth (PEG) Ratio | -0.24 | 0.01 | 0.22 | -0.23 | 0.08 |
| Enterprise Value Multiple | 6.29 | 3.42 | 6.33 | 6.32 | 6.00 |
| Enterprise Value | 28.20B | 23.54B | 21.45B | 19.44B | 22.01B |
| EV to EBITDA | 6.29 | 3.42 | 6.33 | 6.32 | 6.00 |
| EV to Sales | 1.32 | 1.14 | 1.04 | 1.01 | 1.13 |
| EV to Free Cash Flow | 11.15 | 21.09 | 13.22 | 60.55 | 24.19 |
| EV to Operating Cash Flow | 7.97 | 11.50 | 9.04 | 17.95 | 14.04 |
| Tangible Book Value Per Share | -39.63 | -36.54 | -60.68 | -64.89 | -60.85 |
| Shareholders’ Equity Per Share | 46.81 | 43.04 | 15.82 | 10.68 | 9.62 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.23 | 0.19 | 0.26 | 0.22 |
| Revenue Per Share | 236.38 | 213.25 | 202.17 | 179.32 | 182.39 |
| Net Income Per Share | 15.61 | 33.02 | 6.01 | 3.84 | 8.56 |
| Tax Burden | 0.50 | 0.61 | 0.38 | 0.31 | 0.48 |
| Interest Burden | 0.77 | 0.86 | 0.64 | 0.60 | 0.67 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.41 | 0.43 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.52 | 0.50 | 1.81 | 1.08 | 1.06 |
Currency in USD
